ATLASATLAS fair value
₹1,656
Above fair value · 51% premium
Range: ₹1,144–₹1,992Fair valuePrice
Mankind Pharma (MANKIND.NSE)
Mankind Pharma share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India
₹2,503▲ +8.24%
Prices as of Oct 27, 2026 · INR
Chance of rising in 1 month
51%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Mankind Pharma in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Mankind Pharma
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Mankind Pharma's fair value at about ₹1,656 per share (reasonable range: ₹1,144 to ₹1,992). At ₹2,503, the stock trades 51% above it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is high. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Mankind Pharma a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹2,368 and ₹2,652; in 9 out of 10, between ₹2,141 and ₹2,933. Estimated annual volatility is 34%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹931B
- Market cap (USD)
- $9.8B
- P/E ratio
- 50.9
- 52-week high
- ₹2,642
- 52-week low
- ₹1,910
- Revenue (12 months)
- ₹147B
- Operating margin
- 20.6%
- Net margin
- 13.9%
- Beta
- 0.45
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Mankind Pharma sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks MANKIND.NSE has traded between ₹1,910 and ₹2,642. Today it is 5.3% below that high and 31% above its low.
On the business: net margin is 13.9%; it trades at 50.9 times earnings.
Its beta is 0.45: it tends to move less than the market.
About the company
Mankind Pharma Ltd. is a prominent pharmaceutical company based in India, focusing on the development, manufacturing, and marketing of a diverse range of pharmaceutical products.
Want to see everything about Mankind Pharma?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Mankind Pharma (MANKIND.NSE) fair value?
About ₹1,656 per share according to ATLAS (reasonable range: ₹1,144 to ₹1,992). With the stock at ₹2,503, it is 51% above it.
What is the chance MANKIND.NSE goes up next month?
51%: close to a coin flip. In half of the simulated outcomes, MANKIND.NSE ends the month between ₹2,368 and ₹2,652.
How big is Mankind Pharma and what is its P/E ratio?
Mankind Pharma's market capitalization is ₹931B. Its price-to-earnings (P/E) ratio is 50.9: you pay ₹50.9 for each ₹1.00 of yearly earnings.
How volatile is MANKIND.NSE?
ATLAS estimates annual volatility at 34%. In a typical month, half of the outcomes end between ₹2,368 and ₹2,652.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer